| GENE_SYMBOL |
DRUG_NAME |
Ki (nM) |
IC50 (nM) |
Kd (nM) |
EC50 (nM) |
Potency (nM) |
AC50 (nM) |
Datasource |
| JAK2 |
2-(((3R,4S)-3-fluoro-1-((S)-2-hydroxypropanoyl)piperidin-4-yl)oxy)-5-(4-((4-((R)-1-(oxetan-3-yl)pyrrolidin-2-yl)phenyl)amino)-1,3,5-triazin-2-yl)benzonitrile |
NA |
1000000 |
NA |
NA |
NA |
NA |
BindingDB |
| JAK2 |
2-((5-Fluoro-1-(2-hydroxyacetyl)-3,3-dimethylpiperidin-4-yl)oxy)-5-(4-((4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)amino)-1,3,5-triazin-2-yl)benzonitrile |
NA |
117000 |
NA |
NA |
NA |
NA |
BindingDB |
| JAK2 |
US10040781, Example 591 |
NA |
658000 |
NA |
NA |
NA |
NA |
BindingDB |
| JAK2 |
(S)-4-(4-((4-(3-cyano-4-(((3R,4S)-3-fluoro-1-((S)-2-hydroxypropanoyl)piperidin-4-yl)oxy)phenyl)-1,3,5-triazin-2-yl)amino)phenyl)morpholine-2-carboxamide |
NA |
347000 |
NA |
NA |
NA |
NA |
BindingDB |
| JAK2 |
US10040781, Example 551 |
NA |
799000 |
NA |
NA |
NA |
NA |
BindingDB |
| JAK2 |
US10040781, Example 543 |
NA |
1000000 |
NA |
NA |
NA |
NA |
BindingDB |
| JAK2 |
2-(((3R,4S)-1-acetyl-3-fluoropiperidin-4-yl)oxy)-5-(4-((4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)amino)-1,3,5-triazin-2-yl)benzonitrile |
NA |
444000 |
NA |
NA |
NA |
NA |
BindingDB |
| JAK2 |
3-((2-Cyano-4-(4-((4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)amino)-1,3,5-triazin-2-yl)phenoxy)methyl)oxetane-3-carbonitrile |
NA |
216000 |
NA |
NA |
NA |
NA |
BindingDB |
| JAK2 |
US10040781, Example 354 |
NA |
309000 |
NA |
NA |
NA |
NA |
BindingDB |
| JAK2 |
US10040781, Example 363 |
NA |
665000 |
NA |
NA |
NA |
NA |
BindingDB |
| JAK2 |
US10040781, Example 179 |
NA |
234000 |
NA |
NA |
NA |
NA |
BindingDB |
| JAK2 |
US10040781, Example 221 |
NA |
488000 |
NA |
NA |
NA |
NA |
BindingDB |
| JAK2 |
2-(((3R,4S)-3-fluoro-1-((S)-2-hydroxypropanoyl)piperidin-4-yl)oxy)-5-(4-((4-(4-methylpiperazin-1-yl)phenyl)amino)-1,3,5-triazin-2-yl)benzonitrile |
NA |
389000 |
NA |
NA |
NA |
NA |
BindingDB |
| JAK2 |
US10040781, Example 463 |
NA |
272000 |
NA |
NA |
NA |
NA |
BindingDB |
| JAK2 |
US10040781, Example 230 |
NA |
233000 |
NA |
NA |
NA |
NA |
BindingDB |
| JAK2 |
US10040781, Example 367 |
NA |
1000000 |
NA |
NA |
NA |
NA |
BindingDB |
| JAK2 |
US10040781, Example 429 |
NA |
601000 |
NA |
NA |
NA |
NA |
BindingDB |
| JAK2 |
US10040781, Example 432 |
NA |
140000 |
NA |
NA |
NA |
NA |
BindingDB |
| JAK2 |
(S)-2-(3-hydroxypyrrolidin-1-yl)-5-(4-((4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)amino)-1,3,5-triazin-2-yl)benzonitrile |
NA |
315000 |
NA |
NA |
NA |
NA |
BindingDB |
| JAK2 |
US10040781, Example 550 |
NA |
750000 |
NA |
NA |
NA |
NA |
BindingDB |